Osman Elbek
Overview
Explore the profile of Osman Elbek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
194
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Elbek O
Thorac Res Pract
. 2023 Nov;
24(6):325-329.
PMID: 37909831
New developments in bioinformatics, artificial intelligence, and nano-biotechnologies will radically change the practice of medicine to be exhibited in the coming years. One approach that has the potential to carry...
2.
Ay P, Yasin Y, Elbek O, Guner M, Gezer T, Sonmez U, et al.
Tob Induc Dis
. 2022 Nov;
20:92.
PMID: 36381381
Introduction: Plain packaging is one of the critical strategies in eliminating the promotion of tobacco products. Evidence indicates that plain packaging decreases the attractiveness of tobacco products and enhances the...
3.
Babayigit C, Kokturk N, Kul S, Duru Cetinkaya P, Nayci S, Argun Baris S, et al.
Front Med (Lausanne)
. 2022 Sep;
9:894126.
PMID: 36117966
Background And Objectives: Although several repurposed antiviral drugs have been used for the treatment of COVID-19, only a few such as remdesivir and molnupiravir have shown promising effects. The objectives...
4.
Duru Cetinkaya P, Pazarli Bostan P, Salepci B, Dilektasli A, Elbek O, Uyanusta Kucuk F, et al.
Turk Thorac J
. 2022 Jul;
23(4):296-301.
PMID: 35848438
Tobacco addiction, which causes the death of more than 8.5 million people in the world every year, is a preventable global public health problem. There are 1.1 billion adult smokers...
5.
Ercan S, Ergan B, Ozuygur S, Korkmaz P, Tasbakan M, Basoglu O, et al.
Turk Thorac J
. 2022 May;
23(3):225-230.
PMID: 35579229
Objective: A substantial number of patients with coronavirus disease-2019 (COVID-19) demonstrate severe infection. Cytokine storm is an underlying condition that worsens clinical outcomes. As an interleukin-6 receptor antagonist, tocilizumab is...
6.
Aykac N, Elbek O
Turk Thorac J
. 2022 Feb;
23(1):63-69.
PMID: 35110203
Objective: The COVID-19 pandemic has demonstrated that the social determinants of health play a fundamental role in the course of the pandemic. This article aims to reveal the class dynamics...
7.
Kokturk N, Babayigit C, Kul S, Duru Cetinkaya P, Nayci S, Argun Baris S, et al.
Respir Med
. 2021 May;
183:106433.
PMID: 33957434
The COVID-19-related death rate varies between countries and is affected by various risk factors. This multicenter registry study was designed to evaluate the mortality rate and the related risk factors...
8.
Elbek O, Kilinc O, Salepci B, Bostan P, Duru Cetinkaya P, Arpaz S, et al.
Turk Thorac J
. 2021 Mar;
22(1):90-92.
PMID: 33646111
No abstract available.
9.
Elbek O
Turk Thorac J
. 2020 Dec;
21(6):433-437.
PMID: 33352099
The prison population is one of the high-risk groups for coronavirus disease 2019 (COVID-19) pandemic. Apart from being in disadvantageous settings of "social distancing," people in prisons are frequently elderly...
10.
Kokturk N, Itil B, Altinisik G, Adiguzel N, Akgun M, Akyildiz L, et al.
Turk Thorac J
. 2020 Dec;
21(6):419-432.
PMID: 33352098
It has been more than 3 months now since the first case of COVID-19 was reported in Turkey. Globally, the number of confirmed cases and deaths reached 9,653,048 and 491,128...